ROYALTY SALE AGREEMENTRoyalty Sale Agreement • December 7th, 2006 • Orthovita Inc • Surgical & medical instruments & apparatus • New York
THIS ROYALTY SALE AGREEMENT (“Agreement”) is made and entered into as of this 5th day of December 2006, by and between Orthovita, Inc., a Pennsylvania corporation with principal offices at 77 Great Valley Parkway, Malvern, Pennsylvania 19355 (“Orthovita”), and Angiotech Pharmaceuticals (US), Inc., a Washington corporation with principal offices at 101 W. North Bend Way, Suite 201, PO Box 2840, North Bend, WA 98045 (“Angiotech”).
G500K Royalty Sale Agreement Signed with SilverStream SEZCRoyalty Sale Agreement • February 25th, 2020
Element 25 Limited (ASX:E25) (E25 or Company) is pleased to announce that it has entered into a binding sale and purchase agreement with SilverStream SEZC dba Vox
